Tod Ibrahim and David White discuss what the health care team will look like in a Biden-Harris administration.

Tod Ibrahim and David White review what the federal government is doing to promote awareness of kidney diseases, improve treatment options, and fund research, discovery, and innovation.

Tod Ibrahim and David White discuss the implications of the presidential election and what the new government's agenda could look like.

Tod Ibrahim and David White discuss the latest updates about physician payment and the political issues affecting it.

Dr. Anupam Agarwal, Dr. Cynthia Delgado, and Dr. Masaomi Nangaku talk about the social issues facing nephrology worldwide, including social determinants of health in different countries.

Dr. Anupam Agarwal, Dr. Kenar Jhaveri, and Dr. Kathleen Liu discuss what nephrologists have learned about how COVID-19 affects the kidneys and what remains unclear.

ASN President Dr. Anupam Agarwal talks to Dr. Anna Greka and Dr. Timmy Lee about a number of recent advances in basic and clinical research, as well as opportunities and challenges specific to transforming kidney care.

Tod Ibrahim and David White discuss the ins and outs of the payment models for nephrologists, including what would happen if the ACA is overturned.

Tod Ibrahim and David White talk about the recent death of Supreme Court Justice Ruth Bader Ginsburg and whether politicians will be able to pass another COVID-19 relief bill.

Tod Ibrahim and David White discuss the problems with current reporting of COVID-19 data, as well as how new technology might change the US health care system.